PetDx, The Liquid Biopsy Company for Pets is a San Diego-based molecular diagnostics company dedicated to unleashing the power of genomics to improve pet health. The company's flagship product, OncoK9, enables veterinarians to detect cancer in dogs with a simple blood draw. As a first-in-class multi-cancer early detection (MCED) test, OncoK9 employs cutting-edge genomic analysis that leverages next-generation sequencing (NGS) technology and proprietary bioinformatics algorithms, empowering veterinarians to provide superior care to canine patients.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
12/09/21	$62,000,000	Series B	Aperture Venture Partners Declaration Partners Friedman BioVentures K4 Family Investments LabCorp Longview Asset Management Torch Capital Valor Equity Partners	undisclosed